Gunjan Verma - India

“This extension will ensure that manufacturers with pending Class C or D Import License applications do not incur any interruptions to their importing activities.”

Gunjan Verma
Managing Partner
Asia Actual India

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sign Up For Our Newsletter to Stay Informed

Sign Up

India Grants Class C and D Import License Grace Period

Published on: September 16th, 2023

Provides Manufacturers with an Additional 6 Months to Complete Application Process

On October 12, 2023, the Central Drugs Standard Control Organisation (CDSCO) issued Circular File No. 29/Misc/03/2023-DC (344) (link), granting a grace period for Import Licenses to qualifying Non-Regulatory Class C and D medical devices. This announcement came nearly two weeks after the October 1st deadline mentioned in G.S.R. 102 (E), which mandates Import Licenses for all Class C and D medical devices imported into India.

This grace period allows Non-Regulatory Class C and D medical devices that were registered and had pending Import License applications as of September 30, 2023, to continue their importation and marketing activities for an additional 6 months while awaiting application review. This process mirrors the one implemented for Class A and B devices last year.

Per the new Circular:

In view of the above, it has been decided that, in case, if an existing importer/manufacturer who is already importing /manufacturing any of the above said Class C or Class D Medical Devices, has submitted application to Central Licensing Authority, for grant of import/manufacturing licensce in respect of the said device(s) under the provisions of Medical Device Rules, 2017, the said application shall be deemed valid and the importer/manufacturer can continue to import /manufacture the said device(s) up to six (6) months from the date of issue of this order or till the time, the Central Licensing Authority, takes a decision on the said application, whichever is earlier.

As stated in G.S.R. 102 (E), released on February 11, 2020, all Class C and D medical devices were to be under the licensing regime beginning October 1, 2023. However, this grace period provides manufacturers with additional time to obtain their Import License(s) and ensures there is no interruption to the medical device supply in India.

For more information on registering your medical device in India, please see our dedicated page on the topic here.

Come Grow With Us

Please contact us if you’d like support from our experienced staff registering your device in India. Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests.

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.

Blog Posts

Changes to Philippines Medical Device Labeling CMDR

Philippines FDA Medical Device Labeling CMDN to CMDR Labeling Guidance

On April 5th, the CDRRHR provided guidance for CMDR medical device labeling in the Philippines related to previously CMDN labeled stock.
Japan's Innovative Medical Device Regulatory Pathway is called Sakigake

Innovative Medical Device Registration in Japan

In 2019, Japan's Ministry of Health, Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) introduced a innovative device registration designation system, called Sakigake, which is meant to streamline the regulatory pathway for qualifying medical products.
PMDA Representative consulting with medical device manufacturers in Japan

Medical Device Consultation in Japan

Medical device consultation in Japan is a very involved but essential process in registering a medical device. A significant part of the regulatory process in Japan is consultation meetings with the Pharmaceuticals and Medical Devices Agency (PMDA).